A novel device for immobilization of babies undergoing upright LP, the present working name (non-proprietary) for the device is LP Comfort Seat (LPCS)
DeviceThe participant will be placed in the LPCS for their lumbar puncture procedure
NCT Number: NCT06811428
A research trial which compares standard of care against employing a novel device for immobilization of babies undergoing upright LP, the present working name for the device is LP Comfort Seat (LPCS).
The research question is:
P: In late-preterm to term babies who are 0-28 days and undergoing LP for R/O Sepsis I: Is the LPCS more effective C: Than human/RN assisted upright positioning O: In generating a higher rate of first attempt LP success
Primary outcome measure is first attempt LP success (any evidence of CSF which is diagnostically useful by content and volume)
Secondary outcome measures could include
1. A qualitatively unadulterated tap (no blood) although as you know this is hard to control even with perfect positioning and technique and single pass 2. A difference in FLACC score as measure of overall pain/comfort between test and control
Trial opening soon.
Get Notified0 day–28 day
All sexes
Interventional
Not applicable
Lay Description: Newborn babies who are unwell sometimes need to undergo a medical procedure known as a 'lumbar puncture' (also called 'spinal tap'). During this procedure, a needle is inserted at the base of the spine to extract fluid from the spinal column. This is most often done to determine if the baby has meningitis. The medical device presented here places the child's comfort and safety at the center of the spinal tap/ lumbar puncture experience and in doing increases the success of this otherwise stressful and technically challenging procedure. This is achieved by placing the child in a stable, firm, but comfortable position nearly eliminating patient motion which otherwise interferes with procedure success, and reduces the variability associated with a human assistant/holder
In the course of routine medical care of infants and young children, it may be necessary to conduct a procedure known as a 'lumbar puncture' or 'spinal tap' which involves insertion of a needle into the base of the spinal column in order to extract fluid for diagnostic purposes. The goal is to obtain a fluid sample with minimal trauma on the first attempt. The target space into which the operator is aiming to access this fluid is approx. 3 mm in diameter. First attempt failure rates range from 30-50%. A second try immediately following a first try, even if successful, leads to more trauma to the patient and often a sub-optimal sample (the "bloody tap") due to surrounding tissue/vascular disruption.
Many factors may contribute to first attempt success in this procedure:
The lumbar puncture procedure may be conducted with the baby placed in a side-lying position. The side-lying position is most common, historically, as the patient seems to be more stable. However the alignment of the spine is often disrupted.
The upright sitting position may also be used. There is recent compelling evidence that this position is superior to the side lying position (NeoCLEAR Study 2023)
The sitting position is associated with better outcomes but is often avoided as the holding technique is more complex
The problem which the current innovation seeks to resolve is the high degree of variability in quality, consistency, and reproducibility of a positioning/immobilization of the neonatal patient during the lumbar puncture procedure.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The participant will be placed in the LPCS for their lumbar puncture procedure
The patient will be held in the upright position by a human assistant
Time frame: Assessed at each procedure
Primary outcome measure is first attempt LP success (any evidence of CSF which is diagnostically useful by content and volume)
Time frame: Assessed at each procedure
A qualitatively unadulterated tap (no blood)
Time frame: Assessed at each procedure
A difference in FLACC score as measure of overall pain/comfort between test and control
Contact information is provided by the study sponsor or research team.
Amanda Latham, N/A
CONTACT
Joel B Cox, Principle Investigator and Sponsor, Doctor of Medicine
CONTACT
Joel Cox
Other
Acronym: NeoCALM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05259683
Bacterial Infections, Bacterial Infections and Mycoses
Belfast, Antrim, United Kingdom
View Trial DetailsNCT00901602
Bacteremia, Bacterial Infections
Beirut, Lebanon
View Trial DetailsNCT04823026
Bacteremia, Bacterial Infections
Copenhagen, Denmark
View Trial DetailsNCT03378258
Bacterial Infections, Bacterial Infections and Mycoses
Belfast, Northern Ireland, United Kingdom
View Trial Details